Skin infections by Staphylococcus aureus and Pseudomonas aeruginosa
|
Commensal, Staphylococcus epidermidis and Micrococcus luteus and pathogenic Staphylococcus aureus and Pseudomonas aeruginosa
|
Immortalized keratinocytes (HaCat cells) |
[102] |
Chronic wound infections |
MRSA, vancomycin-resistant Enterococcus faecalis (VRE) and P. aeruginosa
|
Lubbock Chronic Wound Biofilm (LCWB) model |
[103] |
Wound infections |
Complex polymicrobial biofilms containing Candida albicans, P. aeruginosa, S. aureus, Staphylococcus hominis, Corynebacterium simulans, Streptococcus agalactiae, Finegoldia magna, Prevotella buccalis, Porphyromonas asaccharolytica, Anaerococcus vaginalis, and Peptoniphilus gorbachii
|
Skin epidermis model |
[104] |
Observed in the lungs of cystic fibrosis patients |
C. albicans and P. aeruginosa
|
Caenorhabditis elegans (Nematode) |
[105] |
Chronic wound infections |
S. aureus, P. aeruginosa, E. faecalis and Finegoldia magna
|
Mice |
[57] |
Diabetes-associated manifestations such as lower-limb amputations due to wound infections |
Escherichia coli, Bacteroides fragilis, and Clostridium perfringens
|
Human type 2 diabetes model of mice |
[106] |
Periodontal disease |
Porphyromonas gingivalis and Streptococcus gordonii
|
Murine model of periodontitis |
[107] |
Chronic periodontitis |
P. gingivalis and Treponema denticola
|
Murine model of periodontitis |
[108] |
Otitis media |
Haemophilus influenzae and Moraxella catarrhalis
|
Chinchilla infection model of otitis media |
[109] |
Acute otitis media |
Moraxella catarrhalis, Streptococcus pneumoniae and non-typeable H. influenza
|
In vitro nasopharyngeal colonization model |
[32] |